| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. | Chief Legal Officer | Common Stock | 89.2K | $338K | $3.78 | Sep 29, 2023 | Direct |
| Evofem Biosciences, Inc. | General Counsel and Secretary | Common Stock | 516K | $19.9K | $0.04 | Feb 18, 2022 | Direct |
| ARS Pharmaceuticals, Inc. | Chief Legal Officer | Stock option (right to buy) | 300K | Jan 2, 2024 | Direct | ||
| Evofem Biosciences, Inc. | General Counsel and Secretary | Stock option (right to buy) | 300K | Feb 18, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Chief Legal Officer |
| SPRY | ARS Pharmaceuticals, Inc. | Sep 28, 2023 | 2 | $320K | 4 | Oct 2, 2023 | Chief Legal Officer |
| SPRY | ARS Pharmaceuticals, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Chief Legal Officer |
| SPRY | ARS Pharmaceuticals, Inc. | Dec 1, 2022 | 0 | $0 | 3 | Dec 1, 2022 | Chief Legal Officer |
| EVFM | Evofem Biosciences, Inc. | Feb 18, 2022 | 2 | $0 | 4 | Feb 23, 2022 | General Counsel and Secretary |
| EVFM | Evofem Biosciences, Inc. | Dec 31, 2021 | 1 | $0 | 4 | Jan 4, 2022 | General Counsel and Secretary |
| EVFM | Evofem Biosciences, Inc. | Dec 20, 2021 | 1 | $9.73K | 4 | Dec 20, 2021 | General Counsel and Secretary |
| EVFM | Evofem Biosciences, Inc. | Jun 10, 2021 | 1 | $10.3K | 4 | Jun 10, 2021 | General Counsel and Secretary |
| EVFM | Evofem Biosciences, Inc. | May 20, 2021 | 1 | -$36.2K | 4 | May 21, 2021 | General Counsel and Secretary |